Nesta página
01NRC preço
02Instantâneo
03Gráfico
05Sobre
06Desempenho
07Avaliação e rácios
13Dividendos
14Lucros
15Fundamentos Completos
16Demonstrações
17Investidores institucionais (13F)
18Ativistas e proprietários de 5%+
19Executivos da empresa
20Participação em ETFs
21Consenso
22Pares
23Notícias
26Minhas Métricas
NRC National Research Corporation - Common Stock
NASDAQ · Health Care · Ver em SEC EDGAR ↗ fechar Out 2, 2026 10-K/10-Q Ago 4, 2026
$20,35
· % da faixa de 52 semanas
· acima do mínimo
· para alta
$11,01mínima 52 sem
$23,68máxima 52 sem
Capitalização de Mercado (MRQ)
$451M
P/E (TTM)
0.4
EPS (TTM)
$49.75
Receita (TTM)
$140M
seus distintivos
Intervalo 52 Semanas
$11–$24
Classificação do Analista
BUY
Preço-Alvo
$26
P/E
0.4
ROE
42.0%
Margem de Lucro Líquido
4.2%
Sua barra de distintivos está vazia — fixe uma métrica em qualquer lugar desta página.
NRC Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$20.35
Capitalização de Mercado (MRQ)
$451M
P/E (TTM)
0.4
EPS (TTM)
$49.75
Receita (TTM)
$140M
ROE (TTM)
42.0%
Dívida/Capital (MRQ)
14.4
Intervalo 52 Semanas
$11–$24
NRC Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
intervalo
barras
A granularidade da barra se adapta ao período selecionado — passe o mouse sobre o gráfico para ver a abertura/máxima/mínima/fechamento de uma barra.
Sobre National Research Corporation - Common Stock Visão geral da empresa da Wikipedia
National Research Corporation, doing business as NRC Health, is an American healthcare company which provides healthcare products and subscription-based solutions in United States and Canada. It was founded in 1981, and is based in Lincoln, Nebraska. The company changed its corporate name from National Research Corporation to NRC Health, Inc. in April 2026.
History
National Research Corporation was established in 1981 to provide performance measurement tools and insights for the healthcare industry.
In 1994, the Picker Institute was founded and began development of the Qualisys technology the following year. In 1998, National Research Corporation acquired Healthcare Research Systems, Inc., expanding its offerings in patient experience measurement.
In 2001, the company purchased the Picker Institute's healthcare survey business, enhancing its market presence in patient-centered research. Expansion continued in 2003 with the acquisition of Smaller World Communications, based in Canada.
The company entered the health risk assessment sector in 2005 through the acquisition of Geriatric Health Systems LLC. In 2006, it acquired TGI Group LLC, which led to the creation of The Governance Institute, a resource for healthcare governance education and research.
In 2009, National Research Corporation acquired My InnerView, a firm recognized for its long-term care quality and satisfaction surveys. This was followed in 2010 by the acquisition of OCS HomeCare, a provider of clinical and outcomes analytics for home health and hospice care.
In 2014, the company acquired Digital Assent, the first software platform to enable healthcare organizations to publish physician star ratings based on patient experience data.
In 2016, National Research Corporation rebranded as NRC Health, reflecting a broader commitment to human-centered care and consumer insights.
On February 11, 2020, NRC Health experienced a cyberattack that resulted in the temporary shutdown of its operations and raised concerns about the security of patient data maintained on behalf of its healthcare clients.
Awards
NRC Health is associated with several healthcare recognition programs, including the Consumer Choice Award, the AHCA/NCAL National Quality Award, and Excellence in Action. These programs acknowledge hospitals and long-term care providers based on performance metrics related to patient and resident satisfaction.
In 2010, the company was approved by the Centers for Medicare and Medicaid Services (CMS) as a vendor for the Home Health Consumer Assessment of Healthcare Providers and Systems (HHCAHPS) survey program.
In 2012 and 2013, Modern Healthcare identified NRC Health as the largest patient satisfaction measurement firm in the United States.
Products and services
Products and solutions provided by NRC Health follows the "Eight Dimensions of Patient-Centered Care" philosophy.
Under this strategy, the company provides:
Patient & Family Experience
Resident & Family Experience
Employee Engagement
Physician Engagement
The Consumer Assessment of Healthcare Providers and Systems (CAHPS) program
Market Insights
Healthcare Analytics
Clinical & Outcomes Analytics
Health Risk Assessments
Patient Outreach Programs
Integrated Solutions
The Institutes
CAHPS is a survey system, including HCAHPS, CGCAHPS, HHCAHPS, NHCAHPS, Pediatric HCAHPS, and ICHCAHPS.
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
setorHealth Care
indústriaHealth Care
funcionários357
paísUS
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita$137M2016-12-31 → 2025-12-31
EPS$50.002019-12-31 → 2025-12-31
Fluxo de caixa livre·2016-12-31 → 2024-12-31
Margem líquida4.2%2016-12-31 → 2024-12-31
Avaliação e Proporções
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
| Métrica | Tendência de 5 anos | NRC | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| P/E (TTM) | 0.4média 5A ≈21.4 | ≈21.4 | · | · | |
| P/S (TTM) | 3.2média 5A ≈5.6 | ≈5.6 | 2.1 | Sobreavaliado | |
| P/B (MRQ) | 68.8média 5A ≈14.4 | ≈14.4 | 3.1 | Sobreavaliado | |
| Preço / FCF (TTM) | 20.8média 5A ≈31.2 | ≈31.2 | · | · | |
| Preço / Fluxo de Caixa (TTM) | 15.3média 5A ≈21.2 | ≈21.2 | 12.8 | Sobreavaliado | |
| Preço / Valor Patrimonial Tangível (MRQ) | 101.3 | · | · | · | |
| PEG Ratio | ≈0.0 | · | · | · |
A mediana dos pares é calculada em uma base padronizada por métrica e pode não corresponder sempre à base TTM/MRQ mostrada para esta ação.
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
| Métrica | Tendência de 5 anos | NRC | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Margem Operacional (TTM) | 10.5%média 5A ≈29.1% | ≈29.1% | -0.07% | Fraco | |
| Margem de Impostos Pré-Tributação (TTM) | 6.7%média 5A ≈27.7% | ≈27.7% | 0.46% | Fraco | |
| Margem de Lucro Líquido (TTM) | 4.2%média 5A ≈21.1% | ≈21.1% | -2.6% | Fraco | |
| ROA (TTM) | 4.2%média 5A ≈22.9% | ≈22.9% | 0.70% | Primeira linha | |
| ROE (TTM) | 42.0%média 5A ≈55.8% | ≈55.8% | 10.9% | Primeira linha |
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
| Métrica | Tendência de 5 anos | NRC | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido (MRQ) | 14.4média 5A ≈0.6 | ≈0.6 | 0.0 | Dívida alta | |
| Índice de liquidez corrente (MRQ) | 0.7média 5A ≈1.1 | ≈1.1 | 0.9 | Baixa liquidez | |
| Dívida de Longo Prazo / Patrimônio Líquido (MRQ) | 13.1 | · | · | · |
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
| Métrica | Tendência de 5 anos | NRC | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Revenue YoY (Receita Ano a Ano) | -4.0%média 5A ≈0.76% | ≈0.76% | · | · | |
| Revenue CAGR 3Y (CAGR Receita 3A) | -3.2%média 5A ≈-0.21% | ≈-0.21% | · | · | |
| Revenue CAGR 5Y (CAGR Receita 5A) | 0.61% | · | · | · | |
| EPS YoY | 4707.7%média 5A ≈935.4% | ≈935.4% | · | · | |
| Net Income YoY (Lucro Líquido Ano a Ano) | -53.2%média 5A ≈-18.1% | ≈-18.1% | · | · | |
| EPS CAGR 3Y (CAGR de LPA 3A) | 240.2%média 5A ≈74.9% | ≈74.9% | · | · | |
| EPS CAGR 5Y (CAGR de LPA 5A) | 103.0% | · | · | · | |
| Net Income CAGR 3Y (CAGR de Lucro Líquido 3A) | -28.5%média 5A ≈-15.8% | ≈-15.8% | · | · | |
| Net Income CAGR 5Y (CAGR de Lucro Líquido 5A) | -20.8% | · | · | · |
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
| Métrica | Tendência de 5 anos | NRC | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Revenue / Employee (Receita anual ÷ funcionários (número de funcionários reportado, yfinance). Derivado — não é um conceito SEC-XBRL armazenado.) | ≈$384.8K | · | · | · |
valor · ≈ média 5A · mediana do setor · veredicto relativo à mediana
Dividendos Rendimento, índice de pagamento, histórico de dividendos, CAGR de 5 anos
Pagamento Anualizado≈$0.64
Sequência de Crescimento≈1
| Data ex | Valor | Moeda | Rendimento |
|---|---|---|---|
| Set 25, 2026 | $0,16 | USD | ≈3.3% |
| Jun 26, 2026 | $0,16 | USD | ≈2.9% |
| Mar 27, 2026 | $0,16 | USD | ≈3.3% |
| Dez 26, 2025 | $0,16 | USD | ≈2.8% |
| Set 26, 2025 | $0,12 | USD | ≈3.6% |
| Jun 27, 2025 | $0,12 | USD | ≈2.9% |
| Mar 28, 2025 | $0,12 | USD | ≈3.7% |
| Dez 27, 2024 | $0,12 | USD | ≈2.8% |
| Set 27, 2024 | $0,12 | USD | ≈2.1% |
| Jun 28, 2024 | $0,12 | USD | ≈6.4% |
| Mar 27, 2024 | $0,12 | USD | ≈3.8% |
| Dez 28, 2023 | $0,12 | USD | ≈3.8% |
| Set 28, 2023 | $0,12 | USD | ≈3.9% |
| Set 15, 2023 | $1,00 | USD | ≈3.5% |
| Jun 29, 2023 | $0,12 | USD | ≈1.4% |
| Mar 30, 2023 | $0,12 | USD | ≈1.7% |
| Dez 29, 2022 | $0,12 | USD | ≈2.3% |
| Set 29, 2022 | $0,24 | USD | ≈2.1% |
| Jun 29, 2022 | $0,24 | USD | ≈1.9% |
| Mar 30, 2022 | $0,24 | USD | ≈1.5% |
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
44.0%
Próximo relatório
Out 26, 2026
| Período | Relatório | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|---|
| 30 de Junho de 2026 | Jul 27, 2026 | $0.31 | $0.14 | 119.2% |
| 31 de Março de 2026 | $0.21 | — | — | |
| 31 de Dezembro de 2025 | $0.16 | — | — | |
| 30 de Setembro de 2025 | $0.23 | — | — | |
| 30 de Junho de 2019 | $0.29 | $0.26 | 10.4% | |
| 31 de Março de 2019 | $0.32 | $0.31 | 2.2% |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $137M | $143M | $149M | $152M | $148M | $133M | $128M | $120M | $118M | $109M | $102M | $99M | |
| SG&A Expense | $55M | $45M | $47M | $43M | $39M | $34M | $33M | $31M | $30M | $28M | $27M | $25M | |
| Operating Expenses | $115M | $108M | $109M | $105M | $98M | $91M | $85M | $84M | $83M | $78M | $76M | $71M | |
| Operating Income | $23M | $35M | $40M | $47M | $50M | $43M | $43M | $35M | $34M | $31M | $26M | $28M | |
| Interest Expense | · | $3M | $862.0K | $1M | $2M | $2M | $2M | $2M | $82.0K | $190.0K | $220.0K | $305.0K | |
| Interest Income | $111.0K | $125.0K | $820.0K | $168.0K | $14.0K | $18.0K | $37.0K | $62.0K | $96.0K | $47.0K | $60.0K | $83.0K | |
| Other Non-op | $-95.0K | $-34.0K | $-41.0K | $-118.0K | $4.0K | $585.0K | $-462.0K | $885.0K | $50.0K | $302.0K | $1M | $18.0K | |
| Pretax Income | $18M | $33M | $40M | $43M | $49M | $41M | $41M | $35M | $34M | $31M | $27M | $28M | |
| Income Tax | $6M | $8M | $9M | $11M | $11M | $4M | $8M | $5M | $11M | $11M | $10M | $10M | |
| Net Income | $12M | $25M | $31M | $32M | $37M | $37M | $32M | $30M | $23M | $21M | $18M | $18M | |
| EPS (Basic) | $50.00 | $1.05 | $1.26 | $1.28 | $1.47 | $1.48 | $1.30 | · | · | · | · | · | |
| EPS (Diluted) | $50.00 | $1.04 | $1.25 | $1.27 | $1.46 | $1.45 | $1.26 | · | · | · | · | · | |
| Shares (Basic) | 22,383,000 | 23,703,000 | 24,540,000 | 24,922,000 | 25,422,000 | 25,170,000 | 24,809,000 | · | · | · | · | · | |
| Shares (Diluted) | 22,396,000 | 23,743,000 | 24,673,000 | 25,052,000 | 25,640,000 | 25,696,000 | 25,653,000 | · | · | · | · | · | |
| EBITDA | · | $35M | $40M | $47M | $50M | · | $43M | $35M | $34M | $31M | $26M | $32M |
Balanço Patrimonial
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $4M | $7M | $25M | $54M | $35M | $14M | $13M | $35M | $33M | $42M | $40M | |
| Receivables | $11M | $11M | $12M | $14M | $14M | $14M | $12M | $12M | $15M | $11M | $10M | $8M | |
| Prepaid Expense | $4M | $3M | $4M | $2M | $4M | $3M | $2M | $3M | $2M | $2M | $1M | $1M | |
| Other Current Assets | $520.0K | $692.0K | $940.0K | $1M | $982.0K | $2M | $2M | $224.0K | $35.0K | $35.0K | $34.0K | $994.0K | |
| Current Assets | $20M | $20M | $24M | $44M | $74M | $54M | $29M | $28M | $52M | $47M | $55M | $53M | |
| PP&E (Net) | · | $38M | $28M | $17M | $12M | $12M | $14M | $14M | $12M | $12M | $11M | $12M | |
| PP&E (Gross) | · | $74M | $64M | $51M | $46M | $43M | $42M | $45M | $40M | $38M | $35M | $35M | |
| Accum. Depreciation | · | $35M | $36M | $34M | $33M | $31M | $29M | $31M | $28M | $26M | $23M | $23M | |
| Goodwill | $66M | $66M | $62M | $62M | $62M | $57M | $58M | $58M | $58M | $58M | $58M | $58M | |
| Intangibles | $2M | $3M | $1M | $2M | $2M | $1M | $2M | $2M | $3M | $3M | $4M | $5M | |
| Other Non-current Assets | $3M | $4M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $768.0K | $293.0K | $234.0K | |
| Total Assets | $135M | $133M | $122M | $130M | $158M | $133M | $111M | $108M | $127M | $121M | $128M | $130M | |
| Accounts Payable | $1M | $1M | $1M | $1M | $2M | $1M | $1M | $613.0K | $593.0K | $765.0K | $614.0K | $830.0K | |
| Accrued Liabilities | $3M | $5M | $5M | $4M | $5M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Short-term Debt | $4M | $5M | $7M | $4M | $4M | $4M | $4M | $4M | $1M | $3M | $2M | $2M | |
| Current Liabilities | $37M | $36M | $36M | $33M | $40M | $32M | $38M | $47M | $32M | $32M | $44M | $28M | |
| Capital Leases | $744.0K | $1M | $2M | · | · | · | · | $676.0K | $87.0K | $110.0K | $103.0K | $167.0K | |
| Deferred Tax | $6M | $4M | $4M | $5M | $7M | $7M | $7M | $6M | $4M | $5M | $6M | $7M | |
| Other Non-current Liabilities | $3M | $4M | $4M | $2M | $3M | $4M | $2M | $1M | $935.0K | $777.0K | $575.0K | $541.0K | |
| Total Liabilities | $121M | $101M | $73M | $58M | $72M | $69M | $78M | $89M | $37M | $38M | $54M | $42M | |
| Long-term Debt | $79M | · | $37M | $22M | $27M | $31M | $34M | $38M | $1M | $4M | $6M | $8M | |
| Total Debt | · | $63M | $7M | $4M | $4M | · | $34M | $38M | $2M | $6M | $8M | $10M | |
| Common Stock | $32.0K | $31.0K | $31.0K | $31.0K | $31.0K | $31.0K | $30.0K | $30.0K | $26.0K | · | · | · | |
| Retained Earnings | $-17M | $-17M | $-31M | $-25M | $-36M | $-61M | $-93M | $-106M | $78M | $72M | $65M | $74M | |
| Treasury Stock | $153M | $132M | $99M | $78M | $50M | $44M | $34M | $29M | $37M | $33M | $32M | $30M | |
| AOCI | · | · | · | · | · | · | · | · | · | $-3M | $-3M | $-773.0K | |
| Stockholders' Equity | $14M | $31M | $49M | $72M | $85M | $64M | $33M | $19M | $90M | $83M | $74M | $88M | |
| Liabilities + Equity | $135M | $133M | $122M | $130M | $158M | $133M | $111M | $108M | $127M | $121M | $128M | $130M | |
| Shares Outstanding | 22,637,252 | 23,083,116 | 24,219,887 | 24,628,173 | 25,361,409 | 25,390,968 | 24,947,500 | 24,800,796 | 20,936,703 | · | · | · |
Fluxo de Caixa
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $8M | $6M | $6M | · | · | · | $6M | $5M | $5M | $4M | $4M | $4M | |
| Stock-based Comp | $3M | $284.0K | $935.0K | $1M | $623.0K | $680.0K | $1M | $2M | $2M | $2M | $1M | $742.0K | |
| Deferred Tax | $2M | $-664.0K | $-1M | $-2M | $-277.0K | $-134.0K | $1M | $1M | $-684.0K | $798.0K | $-1M | $107.0K | |
| Amort. of Intangibles | $389.0K | $264.0K | $140.0K | $180.0K | $320.0K | $318.0K | $374.0K | $662.0K | $610.0K | $654.0K | $995.0K | $876.0K | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | · | $3M | |
| Operating Cash Flow | $26M | $35M | $38M | $36M | $46M | $41M | $41M | $40M | $28M | $27M | $22M | $26M | |
| CapEx | $11M | $15M | $16M | $10M | $6M | $4M | $5M | $6M | $5M | $4M | $3M | $2M | |
| Investing Cash Flow | $-11M | $-20M | $-16M | $-10M | $-9M | $-4M | $-5M | $-6M | $-6M | $-4M | $-1M | $-6M | |
| Stock Repurchased | $20M | $31M | $19M | $28M | $4M | · | · | · | · | · | $2M | · | |
| Net Stock Activity | · | $-31M | $-19M | $-28M | $-4M | · | · | · | · | · | $-2M | · | |
| Dividends Paid | $11M | $11M | $36M | $21M | $9M | $11M | $31M | $17M | $17M | $29M | $10M | · | |
| Financing Cash Flow | $-16M | $-17M | $-41M | $-56M | $-18M | $-16M | $-36M | $-54M | $-21M | $-33M | $-17M | $-2M | |
| Net Change in Cash | $-94.0K | $-2M | $-18M | $-29M | $20M | $21M | $526.0K | $-22M | $2M | $-9M | $2M | $18M | |
| Taxes Paid | · | $8M | $9M | $12M | $11M | $5M | $7M | $3M | $13M | $10M | $9M | · | |
| Free Cash Flow | · | $19M | $22M | $26M | $41M | · | $36M | $34M | $24M | $23M | $19M | $24M | |
| Levered FCF | · | $17M | $22M | $26M | $40M | · | $35M | $33M | $23M | $23M | $19M | $24M |
Lucratividade
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | 24.6% | 27.0% | 30.7% | 34.0% | · | 33.6% | 29.5% | 29.1% | 28.5% | 25.8% | 28.6% | |
| Net Margin | · | 17.3% | 20.8% | 21.0% | 25.3% | · | 25.3% | 25.1% | 19.5% | 18.8% | 17.2% | 18.4% | |
| Pretax Margin | · | 22.9% | 26.9% | 28.2% | 32.9% | · | 31.7% | 29.0% | 29.2% | 28.7% | 26.7% | 28.4% | |
| EBITDA Margin | · | 24.6% | 27.0% | 30.7% | 34.0% | · | 33.6% | 29.5% | 29.1% | 28.5% | 25.8% | 32.5% | |
| ROA | · | 19.4% | 24.5% | 22.1% | 25.8% | · | 29.6% | 25.5% | 18.5% | 16.5% | 13.6% | 15.1% | |
| ROE | · | 75.2% | 58.0% | 45.5% | 44.5% | · | 104.8% | 122.1% | 26.6% | 26.1% | 21.7% | 22.8% | |
| ROIC | · | 28.4% | 55.2% | 45.2% | 43.2% | · | 51.3% | 53.6% | 24.8% | 22.9% | 20.7% | 18.6% |
Liquidez e Solvência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 0.5 | 0.7 | 1.3 | 1.8 | · | 0.8 | 0.6 | 1.6 | 1.5 | 1.3 | 1.9 | |
| Quick Ratio | · | 0.4 | 0.5 | 1.2 | 1.7 | · | 0.7 | 0.5 | 1.5 | 1.4 | 1.2 | 1.7 | |
| Debt / Equity | · | 2.0 | 0.1 | 0.1 | 0.1 | · | 1.0 | 2.0 | 0.0 | 0.1 | 0.1 | 0.1 | |
| LT Debt / Equity | · | 1.9 | · | · | · | · | 0.9 | 1.8 | · | 0.0 | 0.0 | 0.1 | |
| Interest Coverage | · | 13.6 | 46.5 | 38.5 | 30.2 | · | 20.6 | 23.3 | 417.3 | 164.2 | 120.2 | 92.8 |
Eficiência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 1.1 | 1.2 | 1.1 | 1.0 | · | 1.2 | 1.0 | 0.9 | 0.9 | 0.8 | 0.8 | |
| Receivables Turnover | · | 12.2 | 11.1 | 10.8 | 10.7 | · | 10.9 | 9.0 | 9.7 | 10.6 | 11.4 | 10.3 |
Por Ação
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $1.36 | $2.02 | $2.92 | $3.36 | · | $1.32 | $0.77 | · | · | · | · | |
| Revenue / Share | · | $6.03 | $6.02 | $6.05 | $5.77 | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | $1.46 | $1.54 | $1.45 | $1.81 | · | · | · | · | · | · | · | |
| Cash / Share | · | $0.18 | $0.27 | $1.02 | $2.14 | · | $0.54 | $0.52 | · | · | · | · | |
| Dividend / Share | $0.52 | $0.48 | $1.48 | $0.84 | $0.48 | $0.21 | $0.78 | · | · | · | · | · | |
| EPS (TTM) | $50.00 | $1.04 | $1.25 | $1.27 | $1.46 | $1.45 | $1.26 | $2.28 | $2.28 | $2.28 | $2.28 | $2.28 |
Taxas de Crescimento
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -4.0% | -3.7% | -2.0% | 2.4% | 11.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -3.2% | -1.1% | 3.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 0.61% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 4707.7% | -16.8% | -1.6% | -13.0% | 0.69% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 240.2% | -10.7% | -4.8% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 103.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -53.2% | -20.0% | -2.6% | -15.1% | 0.55% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -28.5% | -12.9% | -6.0% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -20.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 0.86% | · | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM)
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $137M | $143M | $149M | $152M | $148M | $133M | $128M | $120M | $118M | $109M | $102M | $99M | |
| Net Income TTM | $12M | $25M | $31M | $32M | $37M | $37M | $32M | $30M | $23M | $21M | $18M | $18M | |
| Market Cap | · | $407M | $958M | $919M | $1.05B | · | $1.65B | $946M | · | · | · | · | |
| Enterprise Value | · | $466M | $959M | $898M | $1.00B | · | $1.67B | $971M | · | · | · | · | |
| P/E | 0.4 | 17.0 | 31.6 | 29.4 | 28.4 | 29.5 | 52.3 | 16.7 | 16.4 | 8.3 | 7.0 | 6.1 | |
| P/S | · | 2.8 | 6.4 | 6.1 | 7.1 | · | 12.9 | 7.9 | · | · | · | · | |
| P/B | · | 13.0 | 19.6 | 12.8 | 12.3 | · | 50.0 | 49.6 | · | · | · | · | |
| P / Tangible Book | · | · | · | 104.3 | 48.0 | 192.1 | · | · | · | · | · | · | |
| P / Cash Flow | · | 11.8 | 25.1 | 25.3 | 22.7 | · | 40.2 | 23.7 | · | · | · | · | |
| P / FCF | · | 21.2 | 42.9 | 34.8 | 25.8 | · | 45.4 | 27.9 | · | · | · | · | |
| EV / EBITDA | · | 13.2 | 23.9 | 19.3 | 20.0 | · | 38.7 | 27.5 | · | · | · | · | |
| EV / FCF | · | 24.3 | 42.9 | 34.0 | 24.6 | · | 45.9 | 28.7 | · | · | · | · | |
| EV / Revenue | · | 3.3 | 6.5 | 5.9 | 6.8 | · | 13.0 | 8.1 | · | · | · | · | |
| Dividend Yield | · | 2.8% | 3.8% | 2.3% | 0.87% | · | 1.9% | 1.8% | · | · | · | · | |
| Earnings Yield | 266.4% | 5.9% | 3.2% | 3.4% | 3.5% | 3.4% | 1.9% | 6.0% | 6.1% | 12.0% | 14.2% | 16.3% | |
| Payout Ratio | · | 46.2% | 117.4% | 65.9% | 24.4% | · | 96.6% | 56.1% | 73.5% | 139.2% | 57.1% | · | |
| Annual Payout | $11M | $11M | $36M | $21M | $9M | $11M | $31M | $17M | $17M | $29M | $10M | · |
Demonstração de Resultados
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $35M | $35M | $35M | $35M | $34M | $34M | $37M | $36M | $35M | $35M | $38M | $38M | $36M | $36M | $38M | $38M | |
| SG&A Expense | $23M | $13M | $14M | $12M | $18M | $10M | $11M | $11M | $11M | $11M | $11M | $12M | $12M | $12M | $11M | $11M | |
| Operating Expenses | $39M | $29M | $31M | $27M | $32M | $25M | $27M | $28M | $26M | $27M | $26M | $28M | $27M | $27M | $26M | $27M | |
| Operating Income | $-3M | $6M | $5M | $8M | $2M | $9M | $10M | $8M | $9M | $9M | $12M | $10M | $9M | $9M | $12M | $11M | |
| Interest Expense | · | · | · | $1M | $1M | $899.0K | · | $706.0K | $555.0K | $605.0K | · | $160.0K | $192.0K | $241.0K | $286.0K | $288.0K | |
| Interest Income | $20.0K | $35.0K | $30.0K | $41.0K | $21.0K | $19.0K | $22.0K | $34.0K | $25.0K | $44.0K | $41.0K | $256.0K | $273.0K | $250.0K | $134.0K | $15.0K | |
| Other Non-op | $2.0K | $30.0K | $-61.0K | $-45.0K | $4.0K | $7.0K | $-6.0K | $-12.0K | $-11.0K | $-5.0K | $-13.0K | $-12.0K | $-2.0K | $-14.0K | $-49.0K | $11.0K | |
| Pretax Income | $-5M | $4M | $3M | $6M | $581.0K | $8M | $9M | $7M | $8M | $8M | $11M | $10M | $9M | $9M | $9M | $11M | |
| Income Tax | $-1M | $1M | $1M | $2M | $687.0K | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $3M | $3M | |
| Net Income | $-3M | $3M | $2M | $4M | $-106.0K | $6M | $7M | $6M | $6M | $6M | $9M | $8M | $7M | $7M | $7M | $8M | |
| EPS (Basic) | $-0.15 | $0.14 | $49.58 | $0.18 | $-0.01 | $0.25 | $0.28 | $0.24 | $0.26 | $0.27 | $0.36 | $0.32 | $0.30 | $0.28 | $0.27 | $0.34 | |
| EPS (Diluted) | $-0.15 | $0.14 | $49.58 | $0.18 | $-0.01 | $0.25 | $0.27 | $0.24 | $0.26 | $0.27 | $0.36 | $0.32 | $0.29 | $0.28 | $0.27 | $0.33 | |
| Shares (Basic) | 22,009,000 | 21,799,000 | · | 22,130,000 | 22,658,000 | 22,972,000 | · | 23,721,000 | 23,871,000 | 23,868,000 | · | 24,560,000 | 24,578,000 | 24,585,000 | · | 24,716,000 | |
| Shares (Diluted) | 22,009,000 | 21,911,000 | · | 22,130,000 | 22,658,000 | 22,974,000 | · | 23,745,000 | 23,915,000 | 23,963,000 | · | 24,695,000 | 24,716,000 | 24,738,000 | · | 24,847,000 | |
| EBITDA | $-3M | $6M | · | $8M | $2M | $9M | · | $8M | $9M | $9M | · | $10M | $9M | $9M | · | $11M |
Balanço Patrimonial
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3M | $3M | $4M | $2M | $5M | $3M | $4M | $3M | $485.0K | $2M | · | $4M | $22M | $24M | · | $28M | |
| Receivables | $9M | $11M | $11M | $13M | $12M | $11M | $11M | $11M | $10M | $11M | · | $14M | $12M | $14M | · | $15M | |
| Prepaid Expense | $5M | $6M | $4M | $4M | $5M | $6M | $3M | $5M | $5M | $6M | · | $6M | $6M | $6M | · | $4M | |
| Other Current Assets | $431.0K | $461.0K | $520.0K | $973.0K | $2M | $588.0K | $692.0K | $664.0K | $1M | $777.0K | · | $369.0K | $834.0K | $1M | · | $1M | |
| Current Assets | $23M | $20M | $20M | $20M | $25M | $20M | $20M | $21M | $17M | $20M | · | $25M | $41M | $45M | · | $49M | |
| PP&E (Net) | · | · | · | $41M | $42M | $40M | · | $36M | $34M | $32M | · | $26M | $23M | $19M | · | $16M | |
| PP&E (Gross) | · | · | · | $82M | $81M | $77M | · | $76M | $72M | $69M | · | $63M | $59M | $54M | · | $52M | |
| Accum. Depreciation | · | · | · | $41M | $38M | $37M | · | $40M | $39M | $37M | · | $37M | $36M | $35M | · | $36M | |
| Goodwill | $66M | $66M | $66M | $66M | $66M | $66M | $66M | $66M | $62M | $62M | $62M | $62M | $62M | $62M | · | $62M | |
| Intangibles | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $1M | $1M | · | $2M | $2M | $2M | · | $2M | |
| Other Non-current Assets | $3M | $3M | $3M | $2M | $2M | $3M | $4M | $6M | $2M | $3M | · | $4M | $5M | $4M | · | $3M | |
| Total Assets | $136M | $135M | $135M | $136M | $141M | $135M | $133M | $132M | $119M | $121M | · | $120M | $134M | $134M | · | $135M | |
| Accounts Payable | $1M | $2M | $1M | $1M | $1M | $2M | $1M | $3M | $1M | $2M | · | $1M | $2M | $1M | · | $1M | |
| Accrued Liabilities | $4M | $3M | $3M | $4M | $6M | $5M | $5M | $6M | $5M | $6M | · | $5M | $4M | $4M | · | $5M | |
| Short-term Debt | $4M | $4M | $4M | $4M | $4M | $3M | $5M | $4M | $8M | $8M | · | $5M | $5M | $5M | · | $4M | |
| Current Liabilities | $35M | $38M | $37M | $39M | $36M | $38M | $36M | $44M | $46M | $49M | · | $41M | $34M | $36M | · | $41M | |
| Capital Leases | · | · | $744.0K | · | · | · | $1M | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $6M | $6M | $6M | $3M | $4M | $5M | $4M | $4M | $4M | $4M | · | $5M | $5M | $5M | · | $5M | |
| Other Non-current Liabilities | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | · | $3M | $2M | $2M | · | $2M | |
| Total Liabilities | $130M | $121M | $121M | $121M | $120M | $106M | $101M | $97M | $79M | $84M | · | $62M | $56M | $60M | · | $67M | |
| Long-term Debt | $90M | · | · | · | · | · | · | $49M | $33M | $35M | · | $19M | $20M | $21M | · | $23M | |
| Total Debt | $94M | $78M | · | $80M | $81M | $62M | · | $49M | $33M | $35M | · | $5M | $5M | $5M | · | $4M | |
| Common Stock | $32.0K | $32.0K | $32.0K | $32.0K | $32.0K | $31.0K | $31.0K | $31.0K | $31.0K | $31.0K | · | $31.0K | $31.0K | $31.0K | · | $31.0K | |
| Retained Earnings | $-25M | $-18M | $-17M | $-15M | $-17M | $-14M | $-17M | $-21M | $-24M | $-27M | · | $-36M | $-17M | $-21M | · | $-29M | |
| Treasury Stock | $162M | $154M | $153M | $152M | $143M | $137M | $132M | $125M | $116M | $116M | · | $82M | $82M | $80M | · | $76M | |
| Stockholders' Equity | $7M | $13M | $14M | $14M | $21M | $30M | $31M | $35M | $40M | $37M | $49M | $58M | $78M | $75M | $72M | $68M | |
| Liabilities + Equity | $136M | $135M | $135M | $136M | $141M | $135M | $133M | $132M | $119M | $121M | · | $120M | $134M | $134M | · | $135M | |
| Shares Outstanding | 22,139,315 | 22,536,696 | 22,637,252 | 22,657,421 | 23,103,685 | 22,785,421 | 23,083,116 | 23,476,040 | 23,871,257 | 23,877,315 | · | 24,562,068 | 24,567,092 | 24,599,815 | · | 24,691,246 |
Fluxo de Caixa
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $1M | · | $1M | |
| Stock-based Comp | $7M | $2M | $2M | $925.0K | $307.0K | $171.0K | $188.0K | $189.0K | $-57.0K | $-36.0K | $258.0K | $68.0K | $305.0K | $304.0K | $290.0K | $291.0K | |
| Deferred Tax | $0 | $-36.0K | $3M | $-48.0K | $-2M | $2M | $-546.0K | $18.0K | $110.0K | $-246.0K | $-400.0K | $29.0K | $-373.0K | $-377.0K | $36.0K | $-486.0K | |
| Operating Cash Flow | $1M | $7M | $7M | $14M | $-1M | $7M | $6M | $9M | $7M | $12M | $12M | $10M | $9M | $8M | $8M | $10M | |
| CapEx | $1M | $2M | $1M | $4M | $3M | $3M | $4M | $2M | $5M | $4M | $4M | $4M | $4M | $3M | $2M | $4M | |
| Investing Cash Flow | $-1M | $-2M | $-1M | $-4M | $-3M | $-3M | $-4M | $-6M | $-5M | $-4M | $-4M | $-4M | $-4M | $-3M | $-2M | $-4M | |
| Stock Repurchased | $8M | $2M | $1.0K | $9M | $6M | $5M | $7M | $9M | $0 | $15M | $15M | $309.0K | $2M | $2M | $2M | $3M | |
| Net Stock Activity | · | $-2M | · | · | · | $-5M | · | · | · | $-15M | · | · | · | $-2M | · | · | |
| Dividends Paid | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $28M | $3M | $3M | $6M | $6M | |
| Financing Cash Flow | $718.0K | $-7M | $-4M | $-13M | $7M | $-5M | $-1M | $-17.0K | $-3M | $-13M | $-5M | $-24M | $-6M | $-6M | $-10M | $-10M | |
| Net Change in Cash | $780.0K | $-2M | $2M | $-3M | $3M | $-2M | $772.0K | $3M | $-1M | $-5M | $3M | $-19M | $-1M | $-1M | $-3M | $-5M | |
| Taxes Paid | · | · | · | $373.0K | $3M | $80.0K | $2M | $2M | $4M | $78.0K | $2M | $2M | $4M | $27.0K | $3M | $3M | |
| Free Cash Flow | · | $5M | · | · | · | $4M | · | · | · | $8M | · | · | · | $5M | · | · | |
| Levered FCF | · | · | · | · | · | $3M | · | · | · | $7M | · | · | · | $4M | · | · |
Lucratividade
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -9.2% | 16.0% | · | 22.4% | 4.7% | 25.6% | · | 22.3% | 25.3% | 24.8% | · | 26.2% | 25.9% | 24.7% | · | 29.5% | |
| Net Margin | -9.3% | 9.3% | · | 11.9% | -0.31% | 17.2% | · | 15.9% | 17.6% | 18.0% | · | 20.8% | 20.1% | 19.1% | · | 22.0% | |
| Pretax Margin | -12.8% | 12.6% | · | 18.1% | 1.7% | 23.0% | · | 20.4% | 23.8% | 23.2% | · | 26.5% | 26.1% | 24.7% | · | 28.8% | |
| EBITDA Margin | -9.2% | 16.0% | · | 22.4% | 4.7% | 25.6% | · | 22.3% | 25.3% | 24.8% | · | 26.2% | 25.9% | 24.7% | · | 29.5% | |
| ROA | -2.4% | 2.4% | · | 3.1% | -0.08% | 4.5% | · | 4.5% | 4.9% | 5.0% | · | 6.2% | 5.4% | 4.9% | · | 5.7% | |
| ROE | -23.5% | 14.9% | · | 16.9% | -0.34% | 17.4% | · | 12.3% | 10.5% | 11.4% | · | 12.5% | 9.9% | 8.9% | · | 11.0% | |
| ROIC | -2.3% | 4.5% | · | 5.4% | -0.28% | 7.0% | · | 7.5% | 9.0% | 9.4% | · | 12.5% | 8.8% | 8.8% | · | 11.8% |
Liquidez e Solvência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.7 | 0.5 | · | 0.5 | 0.7 | 0.5 | · | 0.5 | 0.4 | 0.4 | · | 0.6 | 1.2 | 1.3 | · | 1.2 | |
| Quick Ratio | 0.4 | 0.3 | · | 0.4 | 0.5 | 0.4 | · | 0.3 | 0.2 | 0.3 | · | 0.4 | 1.0 | 1.1 | · | 1.1 | |
| Debt / Equity | 14.4 | 5.8 | · | 5.6 | 3.8 | 2.1 | · | 1.4 | 0.8 | 0.9 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| LT Debt / Equity | 13.1 | 5.5 | · | 5.3 | 3.6 | 2.0 | · | 1.3 | 0.6 | 0.7 | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | 5.3 | 1.5 | 9.6 | · | · | · | 14.5 | · | 62.2 | 48.8 | 37.4 | · | 38.6 |
Eficiência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Receivables Turnover | 3.3 | 3.1 | · | 2.9 | 3.0 | 3.0 | · | 2.8 | 3.2 | 2.8 | · | 2.5 | 2.9 | 2.4 | · | 2.4 |
Por Ação
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.30 | $0.60 | · | $0.63 | $0.92 | $1.30 | · | $1.47 | $1.68 | $1.55 | · | $2.36 | $3.16 | $3.04 | · | $2.74 | |
| Revenue / Share | $1.61 | $1.59 | · | $1.56 | $1.50 | $1.46 | · | $1.51 | $1.46 | $1.47 | · | $1.54 | $1.46 | $1.47 | · | $1.52 | |
| Cash Flow / Share | · | $0.33 | · | · | · | $0.29 | · | · | · | $0.50 | · | · | · | $0.31 | · | · | |
| Cash / Share | $0.15 | $0.11 | · | $0.10 | $0.23 | $0.11 | · | $0.15 | $0.02 | $0.07 | · | $0.16 | $0.92 | $0.96 | · | $1.15 | |
| Dividend / Share | $0.16 | $0.16 | $0.16 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $1.12 | $0.12 | $0.12 | $0.12 | $0.24 | |
| EPS (TTM) | $49.75 | $49.89 | · | $0.69 | $0.75 | $1.02 | · | $1.13 | $1.21 | $1.24 | · | $1.16 | $1.17 | $1.21 | · | $1.37 |
Avaliação (TTM)
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $140M | $139M | · | $139M | $140M | $141M | · | $144M | $146M | $147M | · | $149M | $148M | $150M | · | $152M | |
| Net Income TTM | $6M | $9M | · | $16M | $18M | $24M | · | $27M | $29M | $30M | · | $29M | $29M | $30M | · | $35M | |
| Market Cap | $478M | $383M | · | $290M | $388M | $292M | · | $537M | $548M | $946M | · | $1.09B | $1.07B | $1.07B | · | $983M | |
| Enterprise Value | $568M | $458M | · | $367M | $464M | $351M | · | $582M | $581M | $979M | · | $1.09B | $1.05B | $1.05B | · | $959M | |
| P/E | 0.4 | 0.3 | · | 18.5 | 22.4 | 12.5 | · | 20.2 | 19.0 | 31.9 | · | 38.2 | 37.2 | 36.0 | · | 29.1 | |
| P/S | 3.4 | 2.8 | · | 2.1 | 2.8 | 2.1 | · | 3.7 | 3.7 | 6.4 | · | 7.3 | 7.2 | 7.2 | · | 6.5 | |
| P/B | 72.9 | 28.4 | · | 20.2 | 18.2 | 9.8 | · | 15.5 | 13.6 | 25.6 | · | 18.8 | 13.7 | 14.3 | · | 14.5 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | 73.2 | 93.3 | · | 218.3 | |
| P / Cash Flow | · | 53.3 | · | · | · | 43.9 | · | · | · | 78.6 | · | · | · | 138.1 | · | · | |
| EV / Revenue | 4.1 | 3.3 | · | 2.6 | 3.3 | 2.5 | · | 4.0 | 4.0 | 6.6 | · | 7.3 | 7.1 | 7.0 | · | 6.3 | |
| Dividend Yield | 2.7% | 3.1% | · | 3.8% | 2.9% | 3.9% | · | 2.2% | 6.6% | 3.8% | · | 3.6% | 1.7% | 1.9% | · | 1.8% | |
| Earnings Yield | 230.6% | 293.8% | · | 5.4% | 4.5% | 8.0% | · | 4.9% | 5.3% | 3.1% | · | 2.6% | 2.7% | 2.8% | · | 3.4% | |
| Payout Ratio | · | 112.5% | · | · | · | 47.9% | · | · | · | 45.7% | · | · | · | 42.4% | · | · | |
| Annual Payout | $13M | $12M | · | $11M | $11M | $11M | · | $12M | $36M | $36M | · | $39M | $18M | $21M | · | $18M |
Período mais recente à esquerda · valores nulos mostrados como ·
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Receita | $137M | $143M | $149M | $152M | $148M |
| Margem Operacional % | · | 24.6% | 27.0% | 30.7% | 34.0% |
| Lucro líquido | $12M | $25M | $31M | $32M | $37M |
| EPS Diluído | $50.00 | $1.04 | $1.25 | $1.27 | $1.46 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido | · | 2.0 | 0.1 | 0.1 | 0.1 |
| Índice de liquidez corrente | · | 0.5 | 0.7 | 1.3 | 1.8 |
| Índice de Liquidez Seca | · | 0.4 | 0.5 | 1.2 | 1.7 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fluxo de caixa livre | · | $19M | $22M | $26M | $41M |
Investidores institucionais (13F) 133 declarantes · $237.0M total · Em 30 de Setembro de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Detentores
133
Valor detido
$237.0M
Novas posições
18
Posições encerradas
11
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 18 (-1 vs trimestre anterior) | 11 (+1 vs trimestre anterior) | 43 (+14 vs trimestre anterior) | 39 (-15 vs trimestre anterior) | -77K |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | $43.797.714 | 2.030.492 | 18,48% | Ações |
| BlackRock, Inc. | $22.893.428 | 1.061.355 | 9,66% | Ações |
| MORGAN STANLEY | $18.534.465 | 859.269 | 7,82% | Ações |
| VANGUARD GROUP INC | $15.604.984 | 831.379 | 6,58% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $14.377.570 | 666.554 | 6,07% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $10.595.956 | 491.228 | 4,47% | Ações |
| Willis Investment Counsel | $9.378.312 | 434.785 | 3,96% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $9.062.880 | 420.056 | 3,82% | Ações |
| FARMERS & MERCHANTS INVESTMENTS INC | $7.132.099 | 330.649 | 3,01% | Ações |
| RENAISSANCE TECHNOLOGIES LLC | $7.018.533 | 325.384 | 2,96% | Ações |
| STATE STREET CORP | $6.483.381 | 298.384 | 2,74% | Ações |
| HEARTLAND ADVISORS INC | $6.471.000 | 300.000 | 2,73% | Ações |
| Bank of New York Mellon Corp | $5.440.710 | 252.235 | 2,30% | Ações |
| NORTHERN TRUST CORP | $5.138.900 | 238.243 | 2,17% | Ações |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $4.053.434 | 187.920 | 1,71% | Ações |
| WELLS FARGO & COMPANY/MN | $3.874.460 | 179.623 | 1,63% | Ações |
| AQR CAPITAL MANAGEMENT LLC | $2.635.976 | 122.206 | 1,11% | Ações |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2.444.140 | 113.312 | 1,03% | Ações |
| Northwest & Ethical Investments L.P. | $2.208.121 | 102.370 | 0,93% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $2.096.604 | 97.200 | 0,88% | Ações |
| GOLDMAN SACHS GROUP INC | $2.087.458 | 96.776 | 0,88% | Ações |
| JANE STREET GROUP, LLC | $1.884.679 | 87.375 | 0,80% | Ações |
| FIFTH THIRD BANCORP | $1.841.475 | 85.372 | 0,78% | Ações |
| BANK OF AMERICA CORP /DE/ | $1.789.145 | 82.946 | 0,75% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.762.808 | 81.725 | 0,74% | Ações |
| COMERICA BANK | $1.687.723 | 89.916 | 0,71% | Ações |
| Linden Thomas Advisory Services, LLC | $1.679.311 | 77.854 | 0,71% | Ações |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $1.675.644 | 77.684 | 0,71% | Ações |
| Quantinno Capital Management LP | $1.577.892 | 73.152 | 0,67% | Ações |
| CITADEL ADVISORS LLC | $1.382.529 | 64.095 | 0,58% | Ações |
| TWO SIGMA INVESTMENTS, LP | $1.357.573 | 62.938 | 0,57% | Ações |
| ENVESTNET ASSET MANAGEMENT INC | $1.354.184 | 62.781 | 0,57% | Ações |
| SEI INVESTMENTS CO | $1.027.834 | 47.651 | 0,43% | Ações |
| ALPS ADVISORS INC | $1.015.365 | 47.073 | 0,43% | Ações |
| Williams Jones Wealth Management, LLC. | $901.626 | 41.800 | 0,38% | Ações |
| AMERICAN CENTURY COMPANIES INC | $831.847 | 38.565 | 0,35% | Ações |
| Squarepoint Ops LLC | $798.112 | 37.001 | 0,34% | Ações |
| US BANCORP \DE\ | $715.175 | 33.156 | 0,30% | Ações |
| Nuveen, LLC | $653.959 | 30.318 | 0,28% | Ações |
| HSBC HOLDINGS PLC | $634.793 | 29.539 | 0,27% | Ações |
| Daiwa Securities Group Inc. | $629.218 | 29.171 | 0,27% | Ações |
| Creative Planning | $624.487 | 28.952 | 0,26% | Ações |
| MARSHALL WACE, LLP | $502.193 | 23.282 | 0,21% | Ações |
| Empirical Finance, LLC | $431.400 | 20.000 | 0,18% | Ações |
| Invesco Ltd. | $429.847 | 19.928 | 0,18% | Ações |
| Cove Street Capital, LLC | $417.063 | 32.634 | 0,18% | Ações |
| OSAIC HOLDINGS, INC. | $389.338 | 18.050 | 0,16% | Ações |
| AMERIPRISE FINANCIAL INC | $366.928 | 17.007 | 0,15% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $351.591 | 16.300 | 0,15% | Opção de venda |
| ALLIANCEBERNSTEIN L.P. | $321.007 | 18.905 | 0,14% | Ações |
Ativistas e proprietários de 5%+ 6 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Common Property Trust, Common Property Trust LLC, Amandla, LLC, Beans Patrick E., Hays Michael D. ×3 declarações | 12 de Junho de 2026 | 45,70% | Emenda | · | SEC |
| Thomas Richardson, as the Trustee of Common Property Trust and as Manager of Common Property Trust LLC, Common Property Trust, Common Property Trust LLC ( ×2 declarações | 5 de Março de 2024 | · | Declaração inicial | · | SEC |
| Patrick E. Beans, as the Special Holdings Direction Adviser under the Amandla MK Trust, Amandla MK Trust ×9 declarações | 4 de Janeiro de 2024 | · | Declaração inicial | · | SEC |
| Patrick E. Beans, as the Special Holdings Direction Adviser under the K/I/E Trust Under Agreement 10/24/18, K/I/E Trust Under Agreement 10/24/18 | 15 de Março de 2021 | · | Declaração inicial | · | SEC |
| Kent E. Endacott, as the Special Holdings Direction Adviser under the K/I/E/ Trust Under Agreement 3/9/09 (f/k/a Michael and Karen Hays Grandchildren’s Trust dated March 9, 2009), K/I/E/ Trust Under Agreement 3/9/09 (f/k/a Michael and Karen Hays Grandchildren’s Trust dated March 9, 2009) | 25 de Abril de 2018 | · | Declaração inicial | · | SEC |
| Kent E. Endacott, as the Special Holdings Direction Adviser under the Michael and Karen Hays Grandchildren’s Trust dated March 9, 2009, Michael and Karen Hays Grandchildren’s Trust dated March 9, 2009 | 14 de Junho de 2013 | · | Declaração inicial | Investimento passivo | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Executivos da empresa 27 insiders · 13 diretores · 11 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Trent S Green | Chief Executive Officer | 1 de Junho de 2025 A | 500.000 | 0 | 0 | $0 |
| Shane R Harrison | EVP & Chief Financial Officer | 17 de Fevereiro de 2026 P | 8.000 | 1 | 0 | $98.160 |
| Kevin R Karas | SVP Finance, CFO, Treas & Secy | 28 de Fevereiro de 2023 S | 5.384 | 0 | 0 | $0 |
| Steven D. Jackson | President | 1 de Outubro de 2020 F | 55.567 | 0 | 0 | $0 |
| Susan L Henricks | President and COO | 7 de Janeiro de 2014 A | 7.823 | 0 | 0 | $0 |
| Joseph W Carmichael | President | 9 de Maio de 2008 F | 41.872 | 0 | 0 | $0 |
| Helen Hrdy | EVP & Chief Operating Officer | 15 de Dezembro de 2025 M | 140.518 | 0 | 0 | $0 |
| Jona S Raasch | COO, NRC Health | 3 de Abril de 2023 S | 1.688 | 0 | 0 | $0 |
| Jason Russell Rau | Executive Vice President | 12 de Março de 2026 A | 60.000 | 0 | 0 | $0 |
| David Burik | EVP, Strategic Insights | 5 de Janeiro de 2026 A | 100.000 | 0 | 0 | $0 |
| Hays Michael D. | Chairman | 5 de Janeiro de 2026 M | 20.154 | 0 | 0 | $0 |
| Jordan Nicole Freeman | Chief Accounting Officer | 31 de Julho de 2025 P | 771 | 0 | 0 | $0 |
| Andrew Monnich | Chief Corp. Development Off. | 7 de Abril de 2025 A | 100.000 | 0 | 0 | $0 |
| Parul Bhandari | Conselheiro | 23 de Junho de 2026 A | 7.697 | 0 | 0 | $0 |
| Penny Ann Wheeler | Conselheiro | 23 de Junho de 2026 A | 7.697 | 0 | 0 | $0 |
| Stephen H Lockhart | Conselheiro | 23 de Junho de 2026 A | 7.697 | 0 | 0 | $0 |
| Donald M Berwick | Conselheiro | 23 de Junho de 2026 A | 7.697 | 0 | 0 | $0 |
| John N Nunnelly | Conselheiro | 23 de Junho de 2026 A | 40.363 | 0 | 0 | $0 |
| Joann M Martin | Conselheiro | 29 de Junho de 2021 A | 138.955 | 0 | 0 | $0 |
| Barbara Mowry | Conselheiro | 15 de Maio de 2020 M | 42.902 | 0 | 0 | $0 |
| Gail L Warden | Conselheiro | 9 de Maio de 2017 A | 10.263 | 0 | 0 | $0 |
| Paul C Schorr III | Conselheiro | 28 de Outubro de 2013 G | 34.802 | 0 | 0 | $0 |
| Beans Patrick E. | Detentor de 10% | 12 de Maio de 2025 P | 35.003 | 0 | 0 | $0 |
| Common Property Trust | Detentor de 10% | 31 de Dezembro de 2024 G | 4.755.317 | 0 | 0 | $0 |
| Amandla MK Trust | Detentor de 10% | 31 de Dezembro de 2024 G | 0 | 0 | 0 | $0 |
| Michael & Karen Hays Grandchildren's Trust Dated March 9, 2009 | Detentor de 10% | 11 de Março de 2021 S | 0 | 0 | 0 | $0 |
| Karen S Hays | Detentor de 10% | 12 de Fevereiro de 2010 G | 0 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Participação em ETFs Detido por 21 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| ROSC · Lattice Strategies Trust | 0,38% | 12.032 NS | 31 de Julho de 2026 | N-PORT |
| IWC · iShares Trust | 0,06% | 40.256 SH | 11 de Setembro de 2026 | Diário |
| IWO · iShares Trust | 0,02% | 111.072 SH | 11 de Setembro de 2026 | Diário |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 13.354 SH | 1 de Outubro de 2026 | Diário |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 68.097 SH | 19 de Agosto de 2026 | Diário |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 12.633 SH | 19 de Agosto de 2026 | Diário |
| IWM · iShares Trust | 0,01% | 301.953 SH | 11 de Setembro de 2026 | Diário |
| DFAS · Dimensional ETF Trust | 0,01% | 62.228 NS | 31 de Julho de 2026 | N-PORT |
| RSSL · Global X Funds | 0,01% | 5.634 NS | 31 de Julho de 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 560 NS | 31 de Julho de 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 2.149 NS | 31 de Julho de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 1.985 NS | 31 de Julho de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 17.485 NS | 31 de Julho de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 4.118 NS | 31 de Julho de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 23.452 SH | 11 de Setembro de 2026 | Diário |
| IWV · iShares Trust | 0,00% | 3.867 SH | 3 de Setembro de 2026 | Diário |
| DFUS · Dimensional ETF Trust | 0,00% | 2.478 NS | 31 de Julho de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 151.126 SH | 19 de Agosto de 2026 | Diário |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 498.279 SH | 19 de Agosto de 2026 | Diário |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 995 SH | 19 de Agosto de 2026 | Diário |
| SMLF · iShares Trust | · | 66.767 SH | 11 de Setembro de 2026 | Diário |
NRC Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
classificação · 5 analistas
COMPRA
Alvo mediano
$26.00
+27,8%
1 20,0%
Compra forte
3 60,0%
Compra
1 20,0%
Manter
0 0,0%
Venda
0 0,0%
Venda forte
Preço-alvo de 12 meses
1 analistas · 2026-09-27Alvo médio $26.00 +27,8%
Mín$26.00
Média$26.00
Máx$26.00
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
Base do ano fiscal, preços no fechamento do último ano fiscal de cada empresa.
Últimas notícias Notícias recentes mencionando esta empresa
US Nuclear Regulator Seeks Simpler Environmental Reviews To Boost Nuclear Expansion
ZeroHedge · 2 meses, 3 semanas atrás
As Melhores Ações de Energia Nuclear para Comprar e Manter por Décadas
Nasdaq · 4 meses atrás
Em 10 Anos, Você Desejará Ter Comprado Ações da NuScale Power Agora?
Nasdaq · 4 meses, 3 semanas atrás
Oklo vs. NuScale Power: Ambos estão caindo em 2026, mas apenas um vale a pena comprar agora
Nasdaq · 5 meses atrás
Governador do Novo Jersey, Sherrill Lifts 40-Year Nuclear Moratorium
ZeroHedge · 5 meses, 3 semanas atrás
Esta Ação de Energia Nuclear de US$ 10 Pode Ser Seu Ingresso Para o Status de Milionário
Nasdaq · 5 meses, 3 semanas atrás
A NuScale Power Caiu 80% -- Essa é uma Ótima Notícia para Investidores de Longo Prazo
Nasdaq · 5 meses, 4 semanas atrás
"Um Momento Decisivo": Nano Nuclear Apresenta Solicitação De Permissão De Construção Para Reator Kronos Em Illinois
ZeroHedge · 6 meses atrás
Oklo Acaba de Receber uma Licença da NRC. Você Deve Comprar Ações da OKLO Agora?
Yahoo Finance · 6 meses, 1 semana atrás
"Aumento da Demanda por Isótopos Críticos, Oferta Limitada": Oklo Obtém Primeira Licença da NRC e Mais um Marco do DOE
ZeroHedge · 6 meses, 2 semanas atrás
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para si — clique no + ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Fonte: SEC 10-Q arquivado Ago 4, 2026